Vitamin Deficiency Treatment Market Size, Share, Growth, Trends, Scope, Regional Insights and Forecast 2022 - 2030

Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vitamin Deficiency Treatment Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Vitamin Deficiency Treatment Market Analysis and Forecast, 2018–2028

5. Key Insights

5.1. Regulatory Scenario, by Region

5.2. Value Chain Analysis

6. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Product Type, 2018–2028

6.3.1. Vitamin B Complex Supplements

6.3.2. Vitamin C (Ascorbic Acid)

6.3.3. Vitamin A (Retinoids)

6.3.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

6.3.5. Vitamin E (Tocopherol)

6.3.6. Vitamin K

6.4. Market Attractiveness, by Product Type

7. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Route of Administration, 2018–2028

7.3.1. Oral

7.3.2. Parenteral

7.4. Market Attractiveness, by Route of Administration

8. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2018–2028

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness, by Distribution Channel

9. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness, by Region

10. North America Vitamin Deficiency Treatment Market Analysis and Forecast

10.1. Introduction

10.2. Market Value Forecast, by Product Type, 2018–2028

10.2.1. Vitamin B Complex Supplements

10.2.2. Vitamin C (Ascorbic Acid)

10.2.3. Vitamin A (Retinoids)

10.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

10.2.5. Vitamin E (Tocopherol)

10.2.6. Vitamin K

10.3. Market Value Forecast, by Route of Administration, 2018–2028

10.3.1. Oral

10.3.2. Parenteral

10.4. Market Value Forecast, by Distribution Channel, 2018–2028

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. Market Value Forecast, by Country, 2018–2028

10.5.1. U.S.

10.5.2. Canada

10.6. Market Attractiveness Analysis

10.6.1. By Product Type

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country

11. Europe Vitamin Deficiency Treatment Market Analysis and Forecast

11.1. Introduction

11.2. Market Value Forecast, by Product Type, 2018–2028

11.2.1. Vitamin B Complex Supplements

11.2.2. Vitamin C (Ascorbic Acid)

11.2.3. Vitamin A (Retinoids)

11.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

11.2.5. Vitamin E (Tocopherol)

11.2.6. Vitamin K

11.3. Market Value Forecast, by Route of Administration, 2018–2028

11.3.1. Oral

11.3.2. Parenteral

11.4. Market Value Forecast, by Distribution Channel, 2018–2028

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Market Value Forecast, by Country/Sub-region, 2018–2028

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Market Attractiveness Analysis

11.6.1. By Product Type

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Vitamin Deficiency Treatment Market Analysis and Forecast

12.1. Introduction

12.2. Market Value Forecast, by Product Type, 2018–2028

12.2.1. Vitamin B Complex Supplements

12.2.2. Vitamin C (Ascorbic Acid)

12.2.3. Vitamin A (Retinoids)

12.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

12.2.5. Vitamin E (Tocopherol)

12.2.6. Vitamin K

12.3. Market Value Forecast, by Route of Administration, 2018–2028

12.3.1. Oral

12.3.2. Parenteral

12.4. Market Value Forecast, by Distribution Channel, 2018–2028

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Market Value Forecast, by Country/Sub-region, 2018–2028

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Market Attractiveness Analysis

12.6.1. By Product Type

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Vitamin Deficiency Treatment Market Analysis and Forecast

13.1. Introduction

13.2. Market Value Forecast, by Product Type, 2018–2028

13.2.1. Vitamin B Complex Supplements

13.2.2. Vitamin C (Ascorbic Acid)

13.2.3. Vitamin A (Retinoids)

13.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

13.2.5. Vitamin E (Tocopherol)

13.2.6. Vitamin K

13.3. Market Value Forecast, by Route of Administration, 2018–2028

13.3.1. Oral

13.3.2. Parenteral

13.4. Market Value Forecast, by Distribution Channel, 2018–2028

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Market Value Forecast, by Country/Sub-region, 2018–2028

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Product Type

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Vitamin Deficiency Treatment Market Analysis and Forecast

14.1. Introduction

14.2. Market Value Forecast, by Product Type, 2018–2028

14.2.1. Vitamin B Complex Supplements

14.2.2. Vitamin C (Ascorbic Acid)

14.2.3. Vitamin A (Retinoids)

14.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

14.2.5. Vitamin E (Tocopherol)

14.2.6. Vitamin K

14.3. Market Value Forecast, by Route of Administration, 2018–2028

14.3.1. Oral

14.3.2. Parenteral

14.4. Market Value Forecast, by Distribution Channel, 2018–2028

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Market Value Forecast, by Country/Sub-region, 2018–2028

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Market Attractiveness Analysis

14.6.1. By Product Type

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Company Profiles

15.1.1. Merck & Co., Inc.

15.1.1.1. Company Overview

15.1.1.2. Company Financials

15.1.1.3. Growth Strategies

15.1.1.4. SWOT Analysis

15.1.2. Nature’s Bounty

15.1.2.1. Company Overview

15.1.2.2. Growth Strategies

15.1.2.3. SWOT Analysis

15.1.3. Sun Pharmaceutical Industries Ltd.

15.1.3.1. Company Overview

15.1.3.2. Company Financials

15.1.3.3. Growth Strategies

15.1.3.4. SWOT Analysis

15.1.4. Pfizer, Inc.

15.1.4.1. Company Overview

15.1.4.2. Company Financials

15.1.4.3. Growth Strategies

15.1.4.4. SWOT Analysis

15.1.5. Novartis AG

15.1.5.1. Company Overview

15.1.5.2. Company Financials

15.1.5.3. Growth Strategies

15.1.5.4. SWOT Analysis

15.1.6. Cipla, Inc.

15.1.6.1. Company Overview

15.1.6.2. Company Financials

15.1.6.3. Growth Strategies

15.1.6.4. SWOT Analysis

15.1.7. DSM

15.1.7.1. Company Overview

15.1.7.2. Company Financials

15.1.7.3. Growth Strategies

15.1.7.4. SWOT Analysis

15.1.8. BASF SE

15.1.8.1. Company Overview

15.1.8.2. Company Financials

15.1.8.3. Growth Strategies

15.1.8.4. SWOT Analysis

15.1.9. Nestle

15.1.9.1. Company Overview

15.1.9.2. Company Financials

15.1.9.3. Growth Strategies

15.1.9.4. SWOT Analysis

15.1.10. GlaxoSmithKline plc

15.1.10.1. Company Overview

15.1.10.2. Company Financials

15.1.10.3. Growth Strategies

15.1.10.4. SWOT Analysis